$31.35
Currently 23 wall-street analysts regularly analyze the financials of Kymera Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Kymera Therapeutics Inc (KYMR) have a share price target of $58.84. This median of share price forecast represents a 87.69% upside from the latest price of $31.35 as on 06.03.25.
As per the chart shown above, analysts believe that the Kymera Therapeutics Inc (KYMR) share price will touch around $58.84 in next 12-months.
Below is a chart showing the percentage difference between Kymera Therapeutics Inc's share price and its median forecast price. As on 06.03.25, the difference is -19.55%
Based on 23 analysts tracking and researching Kymera Therapeutics Inc (KYMR) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 10 | 10 | 10 |
Outperform | 5 | 5 | 6 |
Hold | 6 | 7 | 7 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |